Evidence from animal models points to tumor-derived transforming growth factor beta 1 (TGF-β1) as a key mediator in converting fibroblasts in the tumor stroma to alpha-smooth muscle actin (αSMA)-expressing myofibroblasts termed cancer-associated myofibroblasts or CAFs2. This evidence concerns the gene TGFB1 and neoplasm.